FDA Adverse Event Injury Summary report: N

FLEXICAP

MDR report key: 2132800 · Received June 17, 2011

Report

Report Number
1423500-2011-07776
Event Type
Injury
Date Received
June 17, 2011
Date of Event
May 1, 2011
Report Date
May 25, 2011
Manufacturer
BAXTER HEALTHCARE - SWINFORD
Product Code
KDJ
PMA / PMN Number
K972579
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

(B)(4) - AS THE DATE OF ONSET OF THIS PERITONITIS EVENT IS UNKNOWN THE SAMPLE WAS NOT REQUESTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, AND/OR UPON CONCLUSION OF BAXTER'S INVESTIGATION A FOLLOW-UP REPORT WILL BE SUBMITTED. THIS IS THE SECOND OF FIVE REPORTS ASSOCIATED WITH THIS EVENT.

Additional Manufacturer Narrative · 1

(B)(4). A BATCH REVIEW WAS PERFORMED FOR POTENTIALLY ASSOCIATED LOT NUMBER 11A19H25 WITH NO DEFECTS NOTED. THE CAUSE OF THE PERITONITIS WAS UNDETERMINED. BAXTER HAS RECEIVED SIMILAR REPORTS FOR THE REPORTED PROBLEM. ADDITIONAL INVESTIGATION IS BEING CONDUCTED THROUGH NCR (B)(4).

Description of Event or Problem · 1

ON (B)(6) 2011, BAXTER RECEIVED A CALL FROM THE HOME PATIENT (HP) WHO REPORTED THAT SHE HAD AN INFECTION AND WAS RECEIVING TREATMENT. ON (B)(6) 2011, BAXTER CONTACTED THE PERITONEAL DIALYSIS NURSE (PDRN) WHO STATED THAT THE HP HAD PERITONITIS WITH SYMPTOM ONSET (B)(6) 2011 OF ABDOMINAL PAIN. ON (B)(6) 2011 PERITONEAL DIALYSIS (PD) EFFLUENT WAS OBTAINED AND TREATMENT PER PROTOCOL WAS INITIATED WITH SINGLE INTRAPERITONEAL (IP) DOSES OF CEFAZOLIN 1GM AND GENTAMICIN 40MG. AFTER CULTURES RESULTED, VANCOMYCIN 2GM IP EVERY 3 DAYS FOR 6 DOSES WAS GIVEN. THE OUTCOME IS ONGOING AND IMPROVED. PD EFFLUENT WILL BE RECULTURED ON OR ABOUT (B)(6) 2011. THE PDRN COULD NOT GIVE CAUSALITY, BUT STATED THAT THE BAXTER PD PRODUCTS WERE NOT RELATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLEXICAP SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ BAXTER HEALTHCARE - SWINFORD

Patients

Seq Age Sex Outcome Treatment
1 32 YR Required Intervention LOCAL(PD4)AMBUFLEX| HOMECHOICE| LOCAL(PD4)ULTRABAG